SEC Form 4 insider trading filings tracked in real time from EDGAR

Poulton Stuart — EVP, Chief Development Officer

Insider trading activity for Poulton Stuart sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: EVP, Chief Development Officer
  • Company: Karyopharm Therapeutics Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $4K
  • Last trade: May 15, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 14, 2026 Poulton Stuart KPTI Karyopharm Therapeutics Inc. SELL 403 $4K
May 13, 2026 Poulton Stuart KPTI Karyopharm Therapeutics Inc. BUY 896 N/A

← All executives · Full trades feed